English

US Oncology Holdings, Inc.

EDGAR

Current report (8-K) · filed 2010-12-30

23 filing records in this dataset, filed from 2005-11-14 to 2010-12-30. Explore the available filing history and original sources.

Some recent filings are joint filings whose figures are reported under another filer: edgar:943061

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

829 million USD

2008-06-30 · USD

Exact inputs and evidence

Revenue: 829175000 USD Source

Operating margin

3.67%

2008-06-30 · %

Exact inputs and evidence

Operating Income: 30431000 USD Source
Revenue: 829175000 USD Source

Operating cash flow

-8.64 million USD

2008-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -8639000 USD Source

Cash and cash equivalents: 78 million USD 2008-06-30 Source
Exact value

78043000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

3.16 billion USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Revenue: 743814000 USD · 2007-07-01 – 2007-09-30 Source
Revenue: 3000778000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 2229208000 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 810607000 USD · 2008-01-01 – 2008-03-31 Source
Revenue: 829175000 USD · 2008-04-01 – 2008-06-30 Source

Net income

-409 million USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Net income: -4194000 USD · 2007-07-01 – 2007-09-30 Source
Net income: -34973000 USD · 2007-01-01 – 2007-12-31 Source
Net income: -20144000 USD · 2007-01-01 – 2007-09-30 Source
Net income: -397388000 USD · 2008-01-01 – 2008-03-31 Source
Net income: 7142000 USD · 2008-04-01 – 2008-06-30 Source

Capital expenditure

82.6 million USD

2006-01-01 – 2006-12-31

Exact inputs and evidence

Capital expenditure: 11768000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 37519000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 11768000 USD · 2006-01-01 – 2006-03-31 Source
Capital expenditure: 57944000 USD · 2006-01-01 – 2006-09-30 Source
Capital expenditure: 37519000 USD · 2006-01-01 – 2006-06-30 Source
Capital expenditure: 82571000 USD · 2006-01-01 – 2006-12-31 Source
Capital expenditure: 57944000 USD · 2006-01-01 – 2006-09-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2010-12-30.

Financial data available through: 2007-12-31.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 3 of 11 periods available· newest 2007-12-31
Operating income: 3 of 11 periods available· newest 2007-12-31
Net income: 3 of 11 periods available· newest 2007-12-31
Operating cash flow: 3 of 11 periods available· newest 2007-12-31
Capital expenditure: 3 of 11 periods available· newest 2007-12-31
Total assets: 3 of 11 periods available· newest 2007-12-31
Total liabilities: 3 of 11 periods available· newest 2007-12-31
Current assets: 3 of 11 periods available· newest 2007-12-31
Current liabilities: 3 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 3 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+6.7%

Prior period

USD 2.81 billion

2006-01-01 – 2006-12-31
Current period

USD 3 billion

2007-01-01 – 2007-12-31

Exact inputs and evidence

3000778000 − 2811383000 = 189395000 USD

2811383000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
3000778000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Year-over-year change in Revenue: 189395000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 3000778000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#15135 Input fundies:Revenue: 2811383000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#15135
The citation records this snapshot. The page link may show a newer release later.
Net income
-233.7%

Prior period

USD 26.16 million

2006-01-01 – 2006-12-31
Current period

−USD 34.97 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

-34973000 − 26158000 = -61131000 USD

26158000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
-34973000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Year-over-year change in Net income: -61131000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -34973000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#17780 Input fundies:NetIncome: 26158000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#17780
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+702.6%

Prior period

USD 20.52 million

2006-01-01 – 2006-12-31
Current period

USD 164.68 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

164677000 − 20517000 = 144160000 USD

20517000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
164677000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Year-over-year change in Operating cash flow: 144160000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 164677000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 Input fundies:OperatingCashFlow: 20517000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+10%

Prior period

USD 82.57 million

2006-01-01 – 2006-12-31
Current period

USD 90.85 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

90850000 − 82571000 = 8279000 USD

82571000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
90850000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Year-over-year change in Capital expenditure: 8279000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 90850000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 Input fundies:CapitalExpenditure: 82571000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 3 billion 100% of revenue
Operating costs Derived USD 2.89 billion 96% of revenue
Operating income USD 113.5 million 3.8% of revenue
Tax, interest and other Derived USD 148.47 million 4.9% of revenue
Net income −USD 34.97 million −1.2% of revenue

Cash

Operating cash flow USD 164.68 million 5.5% of revenue
Capital expenditure USD 90.85 million 3% of revenue
Free cash flow Derived USD 73.83 million 2.5% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2005 95%
2006 94%
2007 Net loss: net income was −1.2% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2005 2005-01-01 – 2005-12-31	2518560000	2381102000 Derived	137458000	118369000 Derived	19089000	29714000 Derived	Source 2005-01-01 – 2005-12-31: 2518560000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 137458000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 19089000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 113914000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 84200000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	2811383000	2646823000 Derived	164560000	138402000 Derived	26158000	-62054000 Derived	Source 2006-01-01 – 2006-12-31: 2811383000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 164560000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 26158000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 20517000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 82571000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	3000778000	2887281000 Derived	113497000	148470000 Derived	-34973000	73827000 Derived	Source 2007-01-01 – 2007-12-31: 3000778000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 113497000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: -34973000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 164677000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 90850000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 3B 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Revenue	2518560000	Revenue: 2518560000 Open source
20062006-12-31	Revenue	2811383000	Revenue: 2811383000 Open source
20072007-12-31	Revenue	3000778000	Revenue: 3000778000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

6.7% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Year over year	No prior comparable period	Revenue: 2518560000 Open source
20062006-12-31	Year over year	11.6%	Revenue: 2811383000 Open source Revenue: 2518560000 Open source
20072007-12-31	Year over year	6.7%	Revenue: 3000778000 Open source Revenue: 2811383000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 3.8% 2007

Net margin -1.2% 2007

Free cash flow margin 2.5% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Operating margin	5.5%	Operating Income: 137458000 Open source Revenue: 2518560000 Open source
20062006-12-31	Operating margin	5.9%	Operating Income: 164560000 Open source Revenue: 2811383000 Open source
20072007-12-31	Operating margin	3.8%	Operating Income: 113497000 Open source Revenue: 3000778000 Open source
20052005-12-31	Net margin	0.8%	Net Income: 19089000 Open source Revenue: 2518560000 Open source
20062006-12-31	Net margin	0.9%	Net Income: 26158000 Open source Revenue: 2811383000 Open source
20072007-12-31	Net margin	-1.2%	Net Income: -34973000 Open source Revenue: 3000778000 Open source
20052005-12-31	Free cash flow margin	1.2%	Revenue: 2518560000 Open source Operating Cash Flow: 113914000 Open source Capital Expenditure: 84200000 Open source
20062006-12-31	Free cash flow margin	-2.2%	Revenue: 2811383000 Open source Operating Cash Flow: 20517000 Open source Capital Expenditure: 82571000 Open source
20072007-12-31	Free cash flow margin	2.5%	Revenue: 3000778000 Open source Operating Cash Flow: 164677000 Open source Capital Expenditure: 90850000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 164.7M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Operating cash flow	113914000	Operating Cash Flow: 113914000 Open source
20062006-12-31	Operating cash flow	20517000	Operating Cash Flow: 20517000 Open source
20072007-12-31	Operating cash flow	164677000	Operating Cash Flow: 164677000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 73.8M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20052005-12-31	Free cash flow	29714000	Operating Cash Flow: 113914000 Open source Capital Expenditure: 84200000 Open source
20062006-12-31	Free cash flow	-62054000	Operating Cash Flow: 20517000 Open source Capital Expenditure: 82571000 Open source
20072007-12-31	Free cash flow	73827000	Operating Cash Flow: 164677000 Open source Capital Expenditure: 90850000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

92.6% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Liabilities / assets	82.5%	Total Liabilities: 1748792000 Open source Total Assets: 2118974000 Open source
20062006-12-31	Liabilities / assets	84.8%	Total Liabilities: 2006837000 Open source Total Assets: 2366494000 Open source
20072007-12-31	Liabilities / assets	92.6%	Total Liabilities: 2071704000 Open source Total Assets: 2236373000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.43× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20052005-12-31	Current assets / current liabilities	1.45×	Current Assets: 689552000 Open source Current Liabilities: 474597000 Open source
20062006-12-31	Current assets / current liabilities	1.41×	Current Assets: 899080000 Open source Current Liabilities: 637284000 Open source
20072007-12-31	Current assets / current liabilities	1.43×	Current Assets: 776333000 Open source Current Liabilities: 543974000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2005 2005-01-01 – 2005-12-31	USD 19.09 million Exact value Exact value: 19089000 USD 2005-01-01 – 2005-12-31: 19089000 USD Inspect Net Income Open source Share or cite Citation for Net Income · US Oncology Holdings, Inc. · 2005-12-31 US Oncology Holdings, Inc. (edgar:1333191) Net Income: 19089000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 19089000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#17780 The citation records this snapshot. The page link may show a newer release later.	USD 113.91 million Exact value Exact value: 113914000 USD 2005-01-01 – 2005-12-31: 113914000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · US Oncology Holdings, Inc. · 2005-12-31 US Oncology Holdings, Inc. (edgar:1333191) Operating Cash Flow: 113914000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 113914000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 The citation records this snapshot. The page link may show a newer release later.	USD 84.2 million Exact value Exact value: 84200000 USD 2005-01-01 – 2005-12-31: 84200000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · US Oncology Holdings, Inc. · 2005-12-31 US Oncology Holdings, Inc. (edgar:1333191) Capital Expenditure: 84200000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 84200000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 The citation records this snapshot. The page link may show a newer release later.	USD 29.71 million Calculation and evidence 113914000 − 84200000 USD Exact free cash flow: 29714000 USD 2005-01-01 – 2005-12-31: 113914000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 84200000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · US Oncology Holdings, Inc. · 2005-12-31 US Oncology Holdings, Inc. (edgar:1333191) Free cash flow: 29714000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 113914000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 Input fundies:CapitalExpenditure: 84200000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 26.16 million Exact value Exact value: 26158000 USD 2006-01-01 – 2006-12-31: 26158000 USD Inspect Net Income Open source Share or cite Citation for Net Income · US Oncology Holdings, Inc. · 2006-12-31 US Oncology Holdings, Inc. (edgar:1333191) Net Income: 26158000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 26158000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#17780 The citation records this snapshot. The page link may show a newer release later.	USD 20.52 million Exact value Exact value: 20517000 USD 2006-01-01 – 2006-12-31: 20517000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · US Oncology Holdings, Inc. · 2006-12-31 US Oncology Holdings, Inc. (edgar:1333191) Operating Cash Flow: 20517000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20517000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 The citation records this snapshot. The page link may show a newer release later.	USD 82.57 million Exact value Exact value: 82571000 USD 2006-01-01 – 2006-12-31: 82571000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · US Oncology Holdings, Inc. · 2006-12-31 US Oncology Holdings, Inc. (edgar:1333191) Capital Expenditure: 82571000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 82571000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 The citation records this snapshot. The page link may show a newer release later.	−USD 62.05 million Calculation and evidence 20517000 − 82571000 USD Exact free cash flow: -62054000 USD 2006-01-01 – 2006-12-31: 20517000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 82571000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · US Oncology Holdings, Inc. · 2006-12-31 US Oncology Holdings, Inc. (edgar:1333191) Free cash flow: -62054000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20517000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 Input fundies:CapitalExpenditure: 82571000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	−USD 34.97 million Exact value Exact value: -34973000 USD 2007-01-01 – 2007-12-31: -34973000 USD Inspect Net Income Open source Share or cite Citation for Net Income · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Net Income: -34973000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: -34973000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#17780 The citation records this snapshot. The page link may show a newer release later.	USD 164.68 million Exact value Exact value: 164677000 USD 2007-01-01 – 2007-12-31: 164677000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Operating Cash Flow: 164677000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 164677000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 The citation records this snapshot. The page link may show a newer release later.	USD 90.85 million Exact value Exact value: 90850000 USD 2007-01-01 – 2007-12-31: 90850000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Capital Expenditure: 90850000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 90850000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 The citation records this snapshot. The page link may show a newer release later.	USD 73.83 million Calculation and evidence 164677000 − 90850000 USD Exact free cash flow: 73827000 USD 2007-01-01 – 2007-12-31: 164677000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 90850000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · US Oncology Holdings, Inc. · 2007-12-31 US Oncology Holdings, Inc. (edgar:1333191) Free cash flow: 73827000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1333191?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 164677000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18378 Input fundies:CapitalExpenditure: 90850000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/943061/0001193125-08-043939.txt#18430 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

23 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001333191, 1333191, edgar:1333191

US Oncology Holdings, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation